Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
Two mutations in the gene encoding α-synuclein have been linked to early-onset Parkinson's disease 1 , 2 , 3 (PD). α-Synuclein is a component of Lewy bodies, the fibrous cytoplasmic inclusions characteristic of nigral dopaminergic neurons in the PD brain 4 . This connection between genetics and...
Gespeichert in:
Veröffentlicht in: | Nature medicine 1998-11, Vol.4 (11), p.1318-1320 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1320 |
---|---|
container_issue | 11 |
container_start_page | 1318 |
container_title | Nature medicine |
container_volume | 4 |
creator | Lansbury, Peter T Conway, Kelly A Harper, James D |
description | Two mutations in the gene encoding α-synuclein have been linked to early-onset Parkinson's disease
1
,
2
,
3
(PD). α-Synuclein is a component of Lewy bodies, the fibrous cytoplasmic inclusions characteristic of nigral dopaminergic neurons in the PD brain
4
. This connection between genetics and pathology suggests that the α-synuclein mutations may promote PD pathogenesis by accelerating Lewy body formation. To test this, we studied α-synuclein folding and aggregation
in vitro
, in the absence of other Lewy body-associated molecules. We demonstrate here that both mutant forms of α-synuclein (A53T and A30P) are, like wild-type α-synuclein
5
(WT), disordered in dilute solution. However, at higher concentrations, Lewy body-like fibrils and discrete spherical assemblies are formed; most rapidly by A53T. Thus, mutation-induced acceleration of α-synuclein fibril formation may contribute to the early onset of familial PD. |
doi_str_mv | 10.1038/3311 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17108340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17108340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-830d50dcf72b9a66d2bee3e88ba9c6f2f253ea273e5679e349184358a553897e3</originalsourceid><addsrcrecordid>eNpdkN9KwzAYxYMoc24-ghBBvasmzdIml2P4DwZ6oeBdSduvkq1NZpIKfSxfxGcyY2MXXn0fnN85cA5CU0puKWHijjFKj9CY8lmW0Jx8HMef5CIRkmen6Mz7FSGEES5HaCQFkZyLMWrmVQUtOBWgxtrgbx2cxY0unW5xY12ngrYGlwNWuOuDMgH__iR-MH3VQuRbbdbRGSwG5dohscZDwK_KrbXx0VhrD8rDFJ00qvVwvr8T9P5w_7Z4SpYvj8-L-TKpmMhDIhipOamrJk9LqbKsTksABkKUSlZZkzYpZ6DSnAHPcglsJqmYMS4U50zIHNgE3exyN85-9eBD0WkfC7bKgO19QXNKBJuRCF7twMpZ7x00xcbpTrmhoKTYzlls54zYxT6vLzuoD9B-v6hf73QfFfMJrljZ3plY8X_O5Y4zKvQODjmmo1SKgjIq2B_wjoea</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17108340</pqid></control><display><type>article</type><title>Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease</title><source>MEDLINE</source><source>Nature</source><source>SpringerLink Journals - AutoHoldings</source><creator>Lansbury, Peter T ; Conway, Kelly A ; Harper, James D</creator><creatorcontrib>Lansbury, Peter T ; Conway, Kelly A ; Harper, James D</creatorcontrib><description>Two mutations in the gene encoding α-synuclein have been linked to early-onset Parkinson's disease
1
,
2
,
3
(PD). α-Synuclein is a component of Lewy bodies, the fibrous cytoplasmic inclusions characteristic of nigral dopaminergic neurons in the PD brain
4
. This connection between genetics and pathology suggests that the α-synuclein mutations may promote PD pathogenesis by accelerating Lewy body formation. To test this, we studied α-synuclein folding and aggregation
in vitro
, in the absence of other Lewy body-associated molecules. We demonstrate here that both mutant forms of α-synuclein (A53T and A30P) are, like wild-type α-synuclein
5
(WT), disordered in dilute solution. However, at higher concentrations, Lewy body-like fibrils and discrete spherical assemblies are formed; most rapidly by A53T. Thus, mutation-induced acceleration of α-synuclein fibril formation may contribute to the early onset of familial PD.</description><identifier>ISSN: 1078-8956</identifier><identifier>EISSN: 1546-170X</identifier><identifier>DOI: 10.1038/3311</identifier><identifier>PMID: 9809558</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Age of Onset ; Alanine ; alpha-Synuclein ; Amino Acid Substitution ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Circular Dichroism ; Humans ; Infectious Diseases ; Lewy Bodies - pathology ; Lewy Bodies - ultrastructure ; Metabolic Diseases ; Microscopy, Atomic Force ; Microscopy, Electron ; Molecular Medicine ; Mutagenesis, Site-Directed ; Nerve Tissue Proteins - chemistry ; Nerve Tissue Proteins - genetics ; Nerve Tissue Proteins - ultrastructure ; Neurons - pathology ; Neurosciences ; Parkinson Disease - genetics ; Parkinson Disease - pathology ; Parkinson Disease - physiopathology ; Phosphoproteins - genetics ; Point Mutation ; Recombinant Proteins - chemistry ; Recombinant Proteins - ultrastructure ; Substantia Nigra - pathology ; Synucleins ; Threonine</subject><ispartof>Nature medicine, 1998-11, Vol.4 (11), p.1318-1320</ispartof><rights>Nature America Inc. 1998</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-830d50dcf72b9a66d2bee3e88ba9c6f2f253ea273e5679e349184358a553897e3</citedby><cites>FETCH-LOGICAL-c387t-830d50dcf72b9a66d2bee3e88ba9c6f2f253ea273e5679e349184358a553897e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/3311$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/3311$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,2725,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9809558$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lansbury, Peter T</creatorcontrib><creatorcontrib>Conway, Kelly A</creatorcontrib><creatorcontrib>Harper, James D</creatorcontrib><title>Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease</title><title>Nature medicine</title><addtitle>Nat Med</addtitle><addtitle>Nat Med</addtitle><description>Two mutations in the gene encoding α-synuclein have been linked to early-onset Parkinson's disease
1
,
2
,
3
(PD). α-Synuclein is a component of Lewy bodies, the fibrous cytoplasmic inclusions characteristic of nigral dopaminergic neurons in the PD brain
4
. This connection between genetics and pathology suggests that the α-synuclein mutations may promote PD pathogenesis by accelerating Lewy body formation. To test this, we studied α-synuclein folding and aggregation
in vitro
, in the absence of other Lewy body-associated molecules. We demonstrate here that both mutant forms of α-synuclein (A53T and A30P) are, like wild-type α-synuclein
5
(WT), disordered in dilute solution. However, at higher concentrations, Lewy body-like fibrils and discrete spherical assemblies are formed; most rapidly by A53T. Thus, mutation-induced acceleration of α-synuclein fibril formation may contribute to the early onset of familial PD.</description><subject>Age of Onset</subject><subject>Alanine</subject><subject>alpha-Synuclein</subject><subject>Amino Acid Substitution</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Circular Dichroism</subject><subject>Humans</subject><subject>Infectious Diseases</subject><subject>Lewy Bodies - pathology</subject><subject>Lewy Bodies - ultrastructure</subject><subject>Metabolic Diseases</subject><subject>Microscopy, Atomic Force</subject><subject>Microscopy, Electron</subject><subject>Molecular Medicine</subject><subject>Mutagenesis, Site-Directed</subject><subject>Nerve Tissue Proteins - chemistry</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nerve Tissue Proteins - ultrastructure</subject><subject>Neurons - pathology</subject><subject>Neurosciences</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson Disease - physiopathology</subject><subject>Phosphoproteins - genetics</subject><subject>Point Mutation</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - ultrastructure</subject><subject>Substantia Nigra - pathology</subject><subject>Synucleins</subject><subject>Threonine</subject><issn>1078-8956</issn><issn>1546-170X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkN9KwzAYxYMoc24-ghBBvasmzdIml2P4DwZ6oeBdSduvkq1NZpIKfSxfxGcyY2MXXn0fnN85cA5CU0puKWHijjFKj9CY8lmW0Jx8HMef5CIRkmen6Mz7FSGEES5HaCQFkZyLMWrmVQUtOBWgxtrgbx2cxY0unW5xY12ngrYGlwNWuOuDMgH__iR-MH3VQuRbbdbRGSwG5dohscZDwK_KrbXx0VhrD8rDFJ00qvVwvr8T9P5w_7Z4SpYvj8-L-TKpmMhDIhipOamrJk9LqbKsTksABkKUSlZZkzYpZ6DSnAHPcglsJqmYMS4U50zIHNgE3exyN85-9eBD0WkfC7bKgO19QXNKBJuRCF7twMpZ7x00xcbpTrmhoKTYzlls54zYxT6vLzuoD9B-v6hf73QfFfMJrljZ3plY8X_O5Y4zKvQODjmmo1SKgjIq2B_wjoea</recordid><startdate>19981101</startdate><enddate>19981101</enddate><creator>Lansbury, Peter T</creator><creator>Conway, Kelly A</creator><creator>Harper, James D</creator><general>Nature Publishing Group US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19981101</creationdate><title>Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease</title><author>Lansbury, Peter T ; Conway, Kelly A ; Harper, James D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-830d50dcf72b9a66d2bee3e88ba9c6f2f253ea273e5679e349184358a553897e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Age of Onset</topic><topic>Alanine</topic><topic>alpha-Synuclein</topic><topic>Amino Acid Substitution</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Circular Dichroism</topic><topic>Humans</topic><topic>Infectious Diseases</topic><topic>Lewy Bodies - pathology</topic><topic>Lewy Bodies - ultrastructure</topic><topic>Metabolic Diseases</topic><topic>Microscopy, Atomic Force</topic><topic>Microscopy, Electron</topic><topic>Molecular Medicine</topic><topic>Mutagenesis, Site-Directed</topic><topic>Nerve Tissue Proteins - chemistry</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nerve Tissue Proteins - ultrastructure</topic><topic>Neurons - pathology</topic><topic>Neurosciences</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson Disease - physiopathology</topic><topic>Phosphoproteins - genetics</topic><topic>Point Mutation</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - ultrastructure</topic><topic>Substantia Nigra - pathology</topic><topic>Synucleins</topic><topic>Threonine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lansbury, Peter T</creatorcontrib><creatorcontrib>Conway, Kelly A</creatorcontrib><creatorcontrib>Harper, James D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Nature medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lansbury, Peter T</au><au>Conway, Kelly A</au><au>Harper, James D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease</atitle><jtitle>Nature medicine</jtitle><stitle>Nat Med</stitle><addtitle>Nat Med</addtitle><date>1998-11-01</date><risdate>1998</risdate><volume>4</volume><issue>11</issue><spage>1318</spage><epage>1320</epage><pages>1318-1320</pages><issn>1078-8956</issn><eissn>1546-170X</eissn><abstract>Two mutations in the gene encoding α-synuclein have been linked to early-onset Parkinson's disease
1
,
2
,
3
(PD). α-Synuclein is a component of Lewy bodies, the fibrous cytoplasmic inclusions characteristic of nigral dopaminergic neurons in the PD brain
4
. This connection between genetics and pathology suggests that the α-synuclein mutations may promote PD pathogenesis by accelerating Lewy body formation. To test this, we studied α-synuclein folding and aggregation
in vitro
, in the absence of other Lewy body-associated molecules. We demonstrate here that both mutant forms of α-synuclein (A53T and A30P) are, like wild-type α-synuclein
5
(WT), disordered in dilute solution. However, at higher concentrations, Lewy body-like fibrils and discrete spherical assemblies are formed; most rapidly by A53T. Thus, mutation-induced acceleration of α-synuclein fibril formation may contribute to the early onset of familial PD.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>9809558</pmid><doi>10.1038/3311</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-8956 |
ispartof | Nature medicine, 1998-11, Vol.4 (11), p.1318-1320 |
issn | 1078-8956 1546-170X |
language | eng |
recordid | cdi_proquest_miscellaneous_17108340 |
source | MEDLINE; Nature; SpringerLink Journals - AutoHoldings |
subjects | Age of Onset Alanine alpha-Synuclein Amino Acid Substitution Biomedical and Life Sciences Biomedicine Cancer Research Circular Dichroism Humans Infectious Diseases Lewy Bodies - pathology Lewy Bodies - ultrastructure Metabolic Diseases Microscopy, Atomic Force Microscopy, Electron Molecular Medicine Mutagenesis, Site-Directed Nerve Tissue Proteins - chemistry Nerve Tissue Proteins - genetics Nerve Tissue Proteins - ultrastructure Neurons - pathology Neurosciences Parkinson Disease - genetics Parkinson Disease - pathology Parkinson Disease - physiopathology Phosphoproteins - genetics Point Mutation Recombinant Proteins - chemistry Recombinant Proteins - ultrastructure Substantia Nigra - pathology Synucleins Threonine |
title | Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accelerated%20in%20vitro%20fibril%20formation%20by%20a%20mutant%20%CE%B1-synuclein%20linked%20to%20early-onset%20Parkinson%20disease&rft.jtitle=Nature%20medicine&rft.au=Lansbury,%20Peter%20T&rft.date=1998-11-01&rft.volume=4&rft.issue=11&rft.spage=1318&rft.epage=1320&rft.pages=1318-1320&rft.issn=1078-8956&rft.eissn=1546-170X&rft_id=info:doi/10.1038/3311&rft_dat=%3Cproquest_cross%3E17108340%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17108340&rft_id=info:pmid/9809558&rfr_iscdi=true |